Slate Path Capital LP
Q4 2020 13F-HR Holdings
Net value change ($000)
+90,395
(5.1%)
New positions
13
Sold out positions
9
Turnover %
51.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VTRS | 221,788 | NEW |
| MP | 128,680 | NEW |
| SFIX | 63,354 | 91.0% |
| LNG | 59,430 | NEW |
| NYT | 49,391 | 32.6% |
| FCX | 32,887 | 27.9% |
| WMG | 20,265 | 13.5% |
| HIPO | 19,915 | NEW |
| NOV | 17,918 | NEW |
| CHTR | 12,539 | 6.0% |
Top Reduces (Value $000, Stocks/ETFs)
| Mylan II B.V. | -151,192 | -100.0% |
| B | -114,169 | -75.3% |
| SNAP | -113,970 | -100.0% |
| ZG | -78,529 | -100.0% |
| KEX | -46,876 | -100.0% |
| ALNY | -31,013 | -100.0% |
| CYCN | -18,712 | -49.7% |
| VAPOTHERM INC | -16,367 | -46.2% |
| PAAS | -14,754 | -11.0% |
| GPRE | -7,353 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
3,152
(0.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|